HKSE · 6639.HK
Arrail Group Limited
HK$1.83+HK$0.08 (+4.57%)
Arrail Group Limited’s quoted price sits in the lower half of its reported 52-week range, 40.0% below the high.
Loading market information…
HKSE · 0383.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 03:56 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Tian An Medicare Limited’s quoted price sits in the lower half of its reported 52-week range, 34.19% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Tian An Medicare Limited’s forward annual dividend is HK$0.02 per share, paid annual. The forward yield is 2.23% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Tian An Medicare Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
China Medical & HealthCare Group Limited operates as an investment holding company with its core business centered on managing hospitals across the People's Republic of China, Australia, and the Philippines. The company organizes its diverse activities into six principal segments: Healthcare, Eldercare, Property Development, Property Investment, Financial Services, and Securities Trading and Investments. Beyond its hospital operations, the group is involved in the development of independent living units and oversees the project management of health campuses dedicated to elderly care and retirement communities. These comprehensive facilities encompass elderly nursing homes, service apartments, independent living units, a shopping mall, various retail shops, and club amenities. Furthermore, the company develops and divests properties and land parcels, leases out residential and commercial office properties, provides money lending services, and delivers additional healthcare provisions. Its scope also extends to the trade of medical apparatus and related supplies, alongside engaging in the buying and selling of securities listed on international exchanges. Established in 1990, the company adopted its current name, China Medical & HealthCare Group Limited, in February 2016, having previously operated as COL Capital Limited. Its corporate headquarters are located in Wanchai, Hong Kong.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:19 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$1.83+HK$0.08 (+4.57%)
Arrail Group Limited’s quoted price sits in the lower half of its reported 52-week range, 40.0% below the high.
HK$1.56-HK$0.06 (-3.7%)
Honliv Healthcare Management Group Company Limited’s quoted price sits in the lower half of its reported 52-week range, 10.86% below the high.
HK$0.90+HK$0.01 (+0.56%)
Kindstar Globalgene Technology, Inc.’s quoted price sits in the lower half of its reported 52-week range, 33.82% below the high.
HK$11.49+HK$0.49 (+4.45%)
Wenzhou Kangning Hospital Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 1.79% below the high.
HK$2.20HK$0.00 (0.0%)
EuroEyes International Eye Clinic Limited’s quoted price sits in the lower half of its reported 52-week range, 34.33% below the high.
HK$1.06HK$0.00 (0.0%)
Lee's Pharmaceutical Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 46.72% below the high.
HK$1.74+HK$0.06 (+3.57%)
Guangdong Kanghua Healthcare Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 23.68% below the high.
HK$3.39-HK$0.02 (-0.44%)
Hospital Corporation of China Limited’s quoted price sits in the lower half of its reported 52-week range, 50.8% below the high.
